Inovio Pharma (INO) Tops Q2 EPS by 18c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.35 +1.50%
EPS Growth %: +75.9%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: +75.9%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.07), $0.18 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Lemonade launches car insurance in Missouri with Tesla FSD discount
- BQE Water Announces Investor Call for Fall 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
